Seroprevalence of antibodies to pertussis and diphtheria among healthy adults in China

医学 白喉 血清流行率 抗体 接种疫苗 病毒学 免疫学 血清学
作者
Qi Zhang,Fu-lian Han,Nie Qing,Hongyu Ren,Baoqiang Zhang,Qiyong Liu,Qiushui He,Zhujun Shao
出处
期刊:Journal of Infection [Elsevier BV]
卷期号:63 (6): 441-446 被引量:31
标识
DOI:10.1016/j.jinf.2011.07.018
摘要

Despite extensive childhood immunization, pertussis remains one of the world's leading causes of vaccine-preventable deaths. Incidence of pertussis in adolescents and adults has increased in many countries despite high vaccination coverage. In China, booster vaccinations against diphtheria, tetanus and pertussis are not used in adults, and little is known about pertussis incidence in the age group. The aim of this study was to determine seroprevalence of IgG antibodies to pertussis toxin (PT) and diphtheria among adults in China.Blood samples were obtained from 210 healthy adults aged 18-50 years in Weifang city, China during the period of May and June 2010. Serum IgG antibodies against PT (anti-PT IgG) and diphtheria were determined by the commercial ELISA kits, respectively. According to the kit, concentration of anti-PT IgG higher than 30 IU/mL was considered positive. An antibody concentration of ≥ 0.1 IU/mL was defined as evidence of seroprotection against diphtheria.The mean concentration of anti-PT IgG antibodies was 9.95 IU/mL (95% confidence interval (CI) 8.45-11.44). Eleven (5.24%) of the studied subjects were proved to be seropositive to pertussis. Of the 210 subjects, 161 (76.6%) had anti-diphtheria antibody concentration ≥ 0.1 IU/mL and 49 (23.3%) had the antibody concentration between 0.01 and 0.099 IU/mL.Our study indicated that about 5% of adults aged 18-50 years had positive anti-PT IgG antibodies, suggesting that adult pertussis is not uncommon in China. Although a high proportion of studied subjects had a protective level of immunity against diphtheria, the antibody level decreased with the increasing age of adults. Booster vaccinations against pertussis should be considered in adults in China.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
whx发布了新的文献求助10
2秒前
2秒前
2秒前
小马甲应助兴奋海雪采纳,获得30
3秒前
wanci应助lianqing采纳,获得10
3秒前
zhugepengju完成签到,获得积分10
4秒前
张张完成签到,获得积分20
4秒前
为你比拟完成签到,获得积分10
5秒前
充电宝应助HmyGDUT采纳,获得10
5秒前
刘哈哈完成签到 ,获得积分10
5秒前
芽芽豆完成签到 ,获得积分10
5秒前
5秒前
量子星尘发布了新的文献求助30
6秒前
必发Nature发布了新的文献求助10
6秒前
斯文人达完成签到,获得积分20
7秒前
为你比拟发布了新的文献求助200
8秒前
慕青应助哈哈哈嗝采纳,获得10
9秒前
小由发布了新的文献求助10
10秒前
朴素的小霸王完成签到 ,获得积分10
10秒前
BINGBING1230发布了新的文献求助10
11秒前
13秒前
15秒前
上官若男应助16采纳,获得10
16秒前
JamesPei应助科研通管家采纳,获得10
18秒前
lianqing发布了新的文献求助10
18秒前
科研通AI6应助科研通管家采纳,获得10
18秒前
SciGPT应助科研通管家采纳,获得10
18秒前
科研通AI6应助科研通管家采纳,获得10
18秒前
18秒前
Tourist应助科研通管家采纳,获得150
18秒前
Antheali应助科研通管家采纳,获得10
18秒前
tuanheqi应助科研通管家采纳,获得150
18秒前
Tourist应助科研通管家采纳,获得150
18秒前
18秒前
奋斗完成签到,获得积分10
18秒前
科研通AI5应助科研通管家采纳,获得50
19秒前
香蕉觅云应助科研通管家采纳,获得10
19秒前
科研通AI6应助科研通管家采纳,获得10
19秒前
hh应助科研通管家采纳,获得20
19秒前
子车茗应助科研通管家采纳,获得20
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of Milkfat Fractionation Technology and Application, by Kerry E. Kaylegian and Robert C. Lindsay, AOCS Press, 1995 1000
A novel angiographic index for predicting the efficacy of drug-coated balloons in small vessels 500
Textbook of Neonatal Resuscitation ® 500
The Affinity Designer Manual - Version 2: A Step-by-Step Beginner's Guide 500
Affinity Designer Essentials: A Complete Guide to Vector Art: Your Ultimate Handbook for High-Quality Vector Graphics 500
Optimisation de cristallisation en solution de deux composés organiques en vue de leur purification 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5082475
求助须知:如何正确求助?哪些是违规求助? 4299854
关于积分的说明 13397214
捐赠科研通 4123637
什么是DOI,文献DOI怎么找? 2258551
邀请新用户注册赠送积分活动 1262782
关于科研通互助平台的介绍 1196720